Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fertyon-M
- Development stage
- Unknown
- Lead developer
- Liveon Healthcare
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Fertyon-M is an oral dietary supplement developed by Liveon Healthcare specifically for the management of male infertility. It is formulated as a combination of key micronutrients and antioxidants, including L-carnitine L-tartrate, Coenzyme Q10, Zinc, and Lycopene. The supplement aims to improve sperm quality by enhancing mitochondrial energy metabolism and protecting sperm cells from oxidative stress-induced damage. L-carnitine facilitates the transport of long-chain fatty acids into the mitochondria for beta-oxidation, providing essential energy for sperm motility. Coenzyme Q10 and Lycopene act as potent antioxidants to neutralize reactive oxygen species (ROS) that can impair sperm function and DNA integrity. Zinc is included as an essential trace element required for proper spermatogenesis and testosterone synthesis, supporting overall reproductive health.
- Brand names
- Fertyon-M
02
Targets
DNA polymerase familySLC7A1 (Cationic amino acid transporter 1)ND1 (Mitochondrial electron transport chain complex I)
Beyond the preview
Go deeper on Fertyon-M.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fertyon-M.